Skip to main content

Overview

Zev Rosenwaks, M.D., is the Director and Physician-in-Chief of the Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine (CRM). He is Professor of Obstetrics and Gynecology and Reproductive Medicine at Weill Cornell Medical College and Attending Obstetrician-Gynecologist at NewYork-Presbyterian Hospital. In 1994, Dr. Rosenwaks was named the Revlon Distinguished Professor of Reproductive Medicine in Obstetrics and Gynecology. Under his leadership, CRM has become one of the world's leading reproductive endocrinology and assisted reproduction programs.

Dr. Rosenwaks is board certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He is a Fellow of the American College of Obstetricians and Gynecologists and is past President of the Society for Reproductive Endocrinology and the Society for Assisted Reproductive Technology. He is currently Vice President of the New York Obstetrical Society.

Dr. Rosenwaks is internationally renowned for his pioneering work in assisted reproduction. He was the director of the Jones Institute for Reproductive Medicine in Norfolk, Virginia, the unit that achieved the first in vitro fertilization (IVF) pregnancy in the United States. He also developed the United States' first egg donation program and has been instrumental in developing many contemporary ovarian stimulation protocols central to successful IVF. He is also a major contributor to moderate stimulation protocols designed to avoid complications such as ovarian hyperstimulation syndrome.

Dr. Rosenwaks' current research interests include developing morphologic and biologic markers of embryo viability in order to enable single embryo transfer and avoid multiple pregnancies; optimizing preimplantation genetic testing; and deriving human embryonic stem cell lines.

Dr. Rosenwaks serves as an Overseer on Weill Cornell Medical College's Board of Overseers and sits on the Faculty Steering Council and Executive Faculty Council at Weill Cornell. He was recently appointed to serve as a Committee Member for the Institute of Medicine of the National Academy of Medicine. Dr. Rosenwaks has trained over 70 fellows and has received the Weill Cornell Medical College Award for Teaching Excellence. He has published over 340 peer-reviewed articles, 100 invited book chapters and 6 textbooks. Dr. Rosenwaks is an Editorial Editor of Fertility and Sterility and an Associate Editor of Seminars in Reproductive Medicine.

Highlights

  1. 1
    Human reproduction (Oxford, England) · 2020
    PMID: 32348476DOISenior author85 citations
  2. 2
    Human reproduction (Oxford, England) · 2021
    PMID: 33432330DOISenior author21 citations
  3. 3
    Fertility and sterility · 2020
    PMID: 33272641DOISenior author13 citations

Publications

639 publications

Active

3 grants
  • Sub-PI
    Cleavage-stage versus blastocyst-stage embryo transfer in poor prognosis in vitro fertilization patients (PRECiSE trial)
    Patient-Centered Outcomes Research Institute · 2025–2032 · via Beth Israel Deaconess Medical Center, Inc.
    PLACER-2023C3-35477
  • MPI
    AI-Driven Embryo Selection Platform for Enhanced Implantation in IVF: A Phased Development and Randomized Clinical Trial
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2026–2028
    R61HD123536-01
  • PI
    Infertility Reimbursement Program
    New York State Department of Health · 2022–2026
    DOH01-C37757GG-3450000
Completed grants (2)
  • PI
    Infertility Demonstration Program
    New York State Department of Health · 2017–2022
    DOH01-C33104GG-3450000
  • KP
    DNA Helicases as Mediators of Trinucleotide-Repeat Pathology in Fragile X Syndrome
    Tri-Institutional Stem Cell Initiative (Weill Cornell) · 2015–2019 · via Yeshiva University
    TRI-SCI 2014-15

Clinical research

2 studies

Active

1 study
  • PI
    IMPACT AND SUCCESS RATES IF ASSISTED REPRODUCTIVE TECHNOLOGY AND INFERTILITY TREATMENT: AN ANALYSIS OF THE CENTER FOR REPRODUCTIVE MEDICINE?S CLINICAL DATA
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2020)
Completed & closed trials (1)
  • PI
    Impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) / COVID-19 on pregnancy and neonatal outcomes in a patient population conceiving with assisted reproductive technology (ART)
    Weill Medical College of Cornell University · IRB STUDY CLOSURE (as of 2021)

News mentions

Show 1 more mention